{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:46:39Z","timestamp":1792172799583,"version":"4.4.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":2058,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"italian ministry of health","doi-asserted-by":"crossref","award":["RF-2009-1505746"],"award-info":[{"award-number":["RF-2009-1505746"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003196","name":"italian ministry of health","doi-asserted-by":"crossref","award":["PE-2013-02356818"],"award-info":[{"award-number":["PE-2013-02356818"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003196","name":"italian ministry of health","doi-asserted-by":"crossref","award":["RF-2009-1505746"],"award-info":[{"award-number":["RF-2009-1505746"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004710","name":"Fondazione Umberto Veronesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004710","name":"Fondazione Umberto Veronesi","doi-asserted-by":"publisher","award":["year 2012"],"award-info":[{"award-number":["year 2012"]}],"id":[{"id":"10.13039\/501100004710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>A multicentre trial, ICOS-ONE, showed increases above the upper limit of normality of cardiac troponin (cTn) in 27% of patients within 12 months after the end of cancer chemotherapy (CT) with anthracyclines, whether cardiac protection with enalapril was started at study entry in all (prevention arm) or only upon first occurrence on supra-normal cTn (troponin-triggered arm). The aims of the present post hoc analysis were (i) to assess whether anthracycline-based treatment could induce cardiotoxicity over 36 month follow-up and (ii) to describe the time course of three cardiovascular biomarkers (i.e. troponin I cTnI-Ultra, B-type natriuretic peptide BNP, and pentraxin 3 PTX3) and of left ventricular (LV) function up to 36 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Eligible patients were those prescribed first-in-life CT, without evidence of cardiovascular disease, normal cTn, LV ejection fraction (EF) &amp;gt;50%, not on renin-angiotensin aldosterone system antagonists. Patients underwent echocardiography and blood sampling at 24 and 36 months. No differences were observed in biomarker concentration between the two study arms, \u2018prevention\u2019 vs. \u2018troponin-triggered\u2019. During additional follow-up 13 more deaths occurred, leading to a total of 23 (9.5%), all due to a non-cardiovascular cause. No new occurrences of LV-dysfunction were reported. Two additional patients were admitted to the hospital for cardiovascular causes, both for acute pulmonary embolism. No first onset of raised cTnI-Ultra was reported in the extended follow-up. BNP remained within normal range: at 36 months was 23.4 ng\/L, higher (N.S.) than at baseline, 17.6 ng\/L. PTX3 peaked at 5.2 ng\/mL 1 month after CT and returned to baseline values thereafter. cTnI-Ultra peaked at 26 ng\/L 1 month after CT and returned to 3 ng\/L until the last measurement at 36 months. All echocardiographic variables remained stable during follow-up with a median LVEF of 63% and left atrial volume index about 24 mL\/m2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>First-in-life CT with median cumulative dose of anthracyclines of 180 mg\/m2 does not seem to cause clinically significant cardiac injury, as assessed by circulating biomarkers and echocardiography, in patients aged 51 years (median), without pre-existing cardiac disease. This may suggest either a 100% efficacy of enalapril (given as preventive or troponin-triggered) or a reassuringly low absolute cardiovascular risk in this cohort of patients, which may not require intensive cardiologic follow-up.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.12695","type":"journal-article","created":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T01:21:12Z","timestamp":1588382472000},"page":"1452-1466","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Circulating Biomarkers and Cardiac Function Over 3 Years After Chemotherapy with Anthracyclines: The ICOS-ONE Trial"],"prefix":"10.1093","volume":"7","author":[{"given":"Jennifer M.T.A.","family":"Meessen","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Cardinale","sequence":"additional","affiliation":[{"name":"Cardioncology Unit, European Institute of Oncology, I.R.C.C.S. , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Ciceri","sequence":"additional","affiliation":[{"name":"Haematology\/Transplant Unit, IRCCS Ospedale San Raffaele, Universit\u00e0 Vita-Salute , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Sandri","sequence":"additional","affiliation":[{"name":"Laboratory Medicine, Humanitas Clinical and Reseach Center \u2013 IRCCS \u2013 Rozzano , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Civelli","sequence":"additional","affiliation":[{"name":"Department of Cardiology, European Institute of Oncology , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Bottazzi","sequence":"additional","affiliation":[{"name":"Department of Immunology, Humanitas Clinical and Research Center - IRCCS, Rozzano , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GianFranco","family":"Cucchi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ospedale di Sondrio , Sondrio ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Menatti","sequence":"additional","affiliation":[{"name":"Department of Oncology, Ospedale di Sondrio , Sondrio ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Mangiavacchi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Humanitas Clinical and Research Center - IRCCS, Rozzano , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Condorelli","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Humanitas Clinical and Research Center - IRCCS, Rozzano , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Barbieri","sequence":"additional","affiliation":[{"name":"Department of Cardiology, IRCCS Ospedale Sacro Cuore Don Calabria , Negrar ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Gori","sequence":"additional","affiliation":[{"name":"Department of Oncology, IRCCS Ospedale Sacro Cuore Don Calabria , Negrar ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Colombo","sequence":"additional","affiliation":[{"name":"Cardioncology Unit, European Institute of Oncology, I.R.C.C.S. , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Curigliano","sequence":"additional","affiliation":[{"name":"Division of Early Drug Development for Innovative Therapy, Department of Oncology and Hemato-Oncology, University of Milano, European Institute of Oncology , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Salvatici","sequence":"additional","affiliation":[{"name":"Laboratory Medicine, Humanitas Clinical and Reseach Center \u2013 IRCCS \u2013 Rozzano , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Pastori","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ospedale di Vaio , Fidenza ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ghisoni","sequence":"additional","affiliation":[{"name":"Unit\u00e0 Operativa Complessa Cure Palliative, Ospedale di Vaio , Fidenza ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Bianchi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Istituto Oncologico Veneto IOV-IRCCS , Padova ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Falci","sequence":"additional","affiliation":[{"name":"Department of Oncology, Istituto Oncologico Veneto IOV-IRCCS , Padova ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Cortesi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, IRCCS - Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRST , Meldola ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Farolfi","sequence":"additional","affiliation":[{"name":"Department of Oncology, IRCCS - Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRST , Meldola ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Monopoli","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nuovo Ospedale San Giuseppe , Empoli ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Milandri","sequence":"additional","affiliation":[{"name":"Department of Oncology, Nuovo Ospedale San Giuseppe , Empoli ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Bregni","sequence":"additional","affiliation":[{"name":"Department of Oncology, Presidio Ospedaliero di Busto Arsizio , Busto Arsizio ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Malossi","sequence":"additional","affiliation":[{"name":"Department of Oncology, Ospedale Regionale Umberto Parini , Aosta ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Nassiacos","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Presidio Ospedaliero di Saronno , Saronno ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Verusio","sequence":"additional","affiliation":[{"name":"Department of Oncology, Presidio Ospedaliero di Saronno , Saronno ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Staszewsky","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Leone","sequence":"additional","affiliation":[{"name":"Department of Immunology, Humanitas Clinical and Research Center - IRCCS, Rozzano , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Novelli","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Balconi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico B.","family":"Nicolis","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Franzosi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Masson","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Garlanda","sequence":"additional","affiliation":[{"name":"Department of Immunology, Humanitas Clinical and Research Center - IRCCS, Rozzano , Milan ,","place":["Italy"]},{"name":"Humanitas University , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Mantovani","sequence":"additional","affiliation":[{"name":"Department of Immunology, Humanitas Clinical and Research Center - IRCCS, Rozzano , Milan ,","place":["Italy"]},{"name":"Humanitas University , Milan ,","place":["Italy"]},{"name":"The William Harvey Research Institute, Queen Mary University of London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo M.","family":"Cipolla","sequence":"additional","affiliation":[{"name":"Department of Cardiology, European Institute of Oncology , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Latini*","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"ICOS-ONE Study Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,5,1]]},"reference":[{"key":"2026012115034591700_ehf212695-bib-0001","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002661","article-title":"Cancer therapy-related cardiac dysfunction and heart failure: Part 1: definitions, pathophysiology, risk factors, and imaging","volume":"9","author":"Bloom","year":"2016","journal-title":"Circ Heart Fail"},{"key":"2026012115034591700_ehf212695-bib-0002","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","article-title":"Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy","volume":"131","author":"Cardinale","year":"2015","journal-title":"Circulation"},{"key":"2026012115034591700_ehf212695-bib-0003","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur Heart J"},{"key":"2026012115034591700_ehf212695-bib-0004","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.jcmg.2018.03.025","article-title":"Contemporary role of echocardiography for clinical decision making in patients during and after cancer therapy","volume":"11","author":"Liu","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026012115034591700_ehf212695-bib-0005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.clinbiochem.2014.10.013","article-title":"Use of biomarkers for the assessment of chemotherapy-induced cardiac toxicity","volume":"48","author":"Christenson","year":"2015","journal-title":"Clin Biochem"},{"key":"2026012115034591700_ehf212695-bib-0006","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0735-1097(00)00748-8","article-title":"Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy","volume":"36","author":"Cardinale","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"2026012115034591700_ehf212695-bib-0007","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1161\/01.CIR.0000130926.51766.CC","article-title":"Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy","volume":"109","author":"Cardinale","year":"2004","journal-title":"Circulation"},{"key":"2026012115034591700_ehf212695-bib-0008","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.amjcard.2011.01.006","article-title":"Early detection and prediction of cardiotoxicity in chemotherapy-treated patients","volume":"107","author":"Sawaya","year":"2011","journal-title":"Am J Cardiol"},{"key":"2026012115034591700_ehf212695-bib-0009","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jacc.2013.10.061","article-title":"Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab","volume":"63","author":"Ky","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026012115034591700_ehf212695-bib-0010","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1161\/CIRCULATIONAHA.106.635144","article-title":"Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition","volume":"114","author":"Cardinale","year":"2006","journal-title":"Circulation"},{"key":"2026012115034591700_ehf212695-bib-0011","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejca.2018.02.005","article-title":"Anthracycline-induced cardiotoxicity: a multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial","volume":"94","author":"Cardinale","year":"2018","journal-title":"Eur J Cancer"},{"key":"2026012115034591700_ehf212695-bib-0012","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-immunol-030409-101305","article-title":"An integrated view of humoral innate immunity: pentraxins as a paradigm","volume":"28","author":"Bottazzi","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"2026012115034591700_ehf212695-bib-0013","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1161\/01.CIR.0000145167.30987.2E","article-title":"Lipid Assessment Trial Italian Network (LATIN) investigators. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction","volume":"110","author":"Latini","year":"2004","journal-title":"Circulation"},{"key":"2026012115034591700_ehf212695-bib-0014","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/eurjhf\/hfs092","article-title":"Investigators of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA) and GISSI-Heart Failure (GISSI-HF) trials. Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials","volume":"14","author":"Latini","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026012115034591700_ehf212695-bib-0015","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3389\/fimmu.2019.00823","article-title":"Pentraxin 3 in cardiovascular disease","volume":"10","author":"Ristagno","year":"2019","journal-title":"Front Immunol"},{"key":"2026012115034591700_ehf212695-bib-0016","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(17)30535-1","article-title":"Cardiotoxic effects of anthracycline-based therapy: what is the evidence and what are the potential harms?","volume":"18","author":"Levis","year":"2017","journal-title":"Lancet Oncol"},{"key":"2026012115034591700_ehf212695-bib-0017","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/0895-4356(90)90158-L","article-title":"High agreement but low kappa: I. The problems of two paradoxes","volume":"43","author":"Feinstein","year":"1990","journal-title":"J Clin Epidemiol"},{"key":"2026012115034591700_ehf212695-bib-0018","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1515\/CCLM.2009.110","article-title":"Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations","volume":"47","author":"Yamasaki","year":"2009","journal-title":"Clin Chem Lab Med"},{"key":"2026012115034591700_ehf212695-bib-0019","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/sonc.2001.26431","article-title":"Anthracycline-induced cardiomyopathy","volume":"28","author":"Keefe","year":"2001","journal-title":"Semin Oncol"},{"key":"2026012115034591700_ehf212695-bib-0020","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1001\/jamaoncol.2016.1726","article-title":"Angiotensin II-receptor inhibition with candesartan to prevent trastuzumab-related cardiotoxic effects in patients with early breast cancer: a randomized clinical trial","volume":"2","author":"Boekhout","year":"2016","journal-title":"JAMA Oncol"},{"key":"2026012115034591700_ehf212695-bib-0021","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.ijrobp.2018.11.013","article-title":"Early changes in cardiovascular biomarkers with contemporary thoracic radiation therapy for breast cancer, lung cancer, and lymphoma","volume":"103","author":"Demissei","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026012115034591700_ehf212695-bib-0022","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1093\/eurheartj\/ehw022","article-title":"Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 \u00d7 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol","volume":"37","author":"Gulati","year":"2016","journal-title":"Eur Heart J"},{"key":"2026012115034591700_ehf212695-bib-0023","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006513","article-title":"Neurohormonal blockade and circulating cardiovascular biomarkers during anthracycline therapy in breast cancer patients: results from the PRADA (Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy) study","volume":"6","author":"Gulati","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2026012115034591700_ehf212695-bib-0024","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/j.jacc.2013.02.072","article-title":"Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: the OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of Malignant hEmopathies)","volume":"61","author":"Bosch","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026012115034591700_ehf212695-bib-0025","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0735-1097(02)02059-4","article-title":"Plasma brain natriuretic peptide concentration: impact of age and gender","volume":"40","author":"Redfield","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2026012115034591700_ehf212695-bib-0026","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1161\/01.CIR.0000036747.68104.AC","article-title":"Valsartan heart failure trial investigators. Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT)","volume":"106","author":"Latini","year":"2002","journal-title":"Circulation"},{"key":"2026012115034591700_ehf212695-bib-0027","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00712","article-title":"The long pentraxin PTX3 as a link between innate immunity, tissue remodeling, and cancer","volume":"10","author":"Doni","year":"2019","journal-title":"Front Immunol"},{"key":"2026012115034591700_ehf212695-bib-0028","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ijc.32638","article-title":"Serum levels of inflammation-related markers and metabolites predict response to neoadjuvant chemotherapy with and without bevacizumab in breast cancers","volume":"146","author":"Nome","year":"2020","journal-title":"Int J Cancer"},{"key":"2026012115034591700_ehf212695-bib-0029","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1084\/jem.20061301","article-title":"The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps","volume":"204","author":"Jaillon","year":"2007","journal-title":"J Exp Med"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.12695","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.12695","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/7\/4\/1452\/65902045\/eschf_7_4_1452.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/7\/4\/1452\/65902045\/eschf_7_4_1452.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:04:34Z","timestamp":1769025874000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/7\/4\/1452\/8372976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":29,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,5,1]]},"published-print":{"date-parts":[[2020,8,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.12695","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,8]]},"published":{"date-parts":[[2020,5,1]]},"assertion":[{"value":"2019-10-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}